Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc. company information, Employees & Contact Information

Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause. The Company develops medicines for previously untreatable or undertreated diseases and provides meaningful support for healthcare providers and patients and their families. In addition to commercializing its lead asset in North America, Europe and other regions, Rhythm is advancing a broad clinical development program in rare MC4R pathway diseases, as well as investigational MC4R agonists, and a preclinical suite of small molecules for the treatment of congenital hyperinsulinism. At Rhythm, we know our work makes an important difference in the lives of patients and their families around the world. Every employee contributes to the company’s goal of discovering new treatments for rare diseases that no other company is developing. As a fast-growing company with an exciting future, we offer a collaborative environment where employees’ contributions truly matter, which is one of the many reasons we were recognized as one of The Boston Globe’s Top Places to Work in Massachusetts for 2023 and 2024.
Looking for a particular Rhythm Pharmaceuticals Inc. employee's phone or email?

Rhythm Pharmaceuticals Inc. Questions

News

Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 - GlobeNewswire

Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025 GlobeNewswire

Rhythm Pharmaceuticals: Rare Genetic Obesity Pioneer With Excellent Prospects (RYTM) - Seeking Alpha

Rhythm Pharmaceuticals: Rare Genetic Obesity Pioneer With Excellent Prospects (RYTM) Seeking Alpha

Rhythm Pharmaceuticals Announces Q2 Earnings Date and Major Conference Appearance - Stock Titan

Rhythm Pharmaceuticals Announces Q2 Earnings Date and Major Conference Appearance Stock Titan

Rare Disease Biotech Rhythm Pharmaceuticals Sets Dual Conference Appearances in September 2025 - Stock Titan

Rare Disease Biotech Rhythm Pharmaceuticals Sets Dual Conference Appearances in September 2025 Stock Titan

Rhythm Pharmaceuticals Announces Publication of Children’s Book for Patients and Families Living with Bardet-Biedl Syndrome (BBS) - Yahoo Finance

Rhythm Pharmaceuticals Announces Publication of Children’s Book for Patients and Families Living with Bardet-Biedl Syndrome (BBS) Yahoo Finance

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Use in Patients with Bardet-Biedl Syndrome - Yahoo Finance

Rhythm Pharmaceuticals Announces FDA Approval of IMCIVREE® (setmelanotide) for Use in Patients with Bardet-Biedl Syndrome Yahoo Finance

Top Rhythm Pharmaceuticals Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant